192 related articles for article (PubMed ID: 26176534)
41. Stromal cell-derived factor-1 increase alphavbeta3 integrin expression and invasion in human chondrosarcoma cells.
Lai TH; Fong YC; Fu WM; Yang RS; Tang CH
J Cell Physiol; 2009 Feb; 218(2):334-42. PubMed ID: 18814143
[TBL] [Abstract][Full Text] [Related]
42. Cloning and characterizing mutated human stromal cell-derived factor-1 (SDF-1): C-terminal alpha-helix of SDF-1alpha plays a critical role in CXCR4 activation and signaling, but not in CXCR4 binding affinity.
Tan Y; Du J; Cai S; Li X; Ma W; Guo Z; Chen H; Huang Z; Xiao J; Cai L; Cai S
Exp Hematol; 2006 Nov; 34(11):1553-62. PubMed ID: 17046575
[TBL] [Abstract][Full Text] [Related]
43. Notch signaling pathway regulates the growth and the expression of inflammatory cytokines in mouse basophils.
Qu SY; Lin JJ; Zhang J; Song LQ; Yang XM; Wu CG
Cell Immunol; 2017 Aug; 318():29-34. PubMed ID: 28669409
[TBL] [Abstract][Full Text] [Related]
44. Nicotine up-regulates IL-8 expression in human gingival epithelial cells following stimulation with IL-1β or P. gingivalis lipopolysaccharide via nicotinic acetylcholine receptor signalling.
Kashiwagi Y; Yanagita M; Kojima Y; Shimabukuro Y; Murakami S
Arch Oral Biol; 2012 May; 57(5):483-90. PubMed ID: 22119045
[TBL] [Abstract][Full Text] [Related]
45. Investigation of CXCR4 in squamous cell carcinoma of the tongue.
Delilbasi CB; Okura M; Iida S; Kogo M
Oral Oncol; 2004 Feb; 40(2):154-7. PubMed ID: 14693238
[TBL] [Abstract][Full Text] [Related]
46. Nrf2 regulates cellular behaviors and Notch signaling in oral squamous cell carcinoma cells.
Fan H; Paiboonrungruan C; Zhang X; Prigge JR; Schmidt EE; Sun Z; Chen X
Biochem Biophys Res Commun; 2017 Nov; 493(1):833-839. PubMed ID: 28821430
[TBL] [Abstract][Full Text] [Related]
47. [Cross-talk between Notch1 and epidermal growth factor receptor signalling in regulating cell proliferation of human tongue squamous carcinoma cells].
Huang HJ; Ping FY; Hu JA; Zhao SF
Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(46):3289-94. PubMed ID: 20193370
[TBL] [Abstract][Full Text] [Related]
48. Deletion of the COOH-terminal domain of CXC chemokine receptor 4 leads to the down-regulation of cell-to-cell contact, enhanced motility and proliferation in breast carcinoma cells.
Ueda Y; Neel NF; Schutyser E; Raman D; Richmond A
Cancer Res; 2006 Jun; 66(11):5665-75. PubMed ID: 16740704
[TBL] [Abstract][Full Text] [Related]
49. TRPV4 mediates IL-1-induced Ca
Wang Q; Ji C; Ali A; Ding I; Wang Y; McCulloch CA
FASEB J; 2024 Jun; 38(11):e23731. PubMed ID: 38855909
[TBL] [Abstract][Full Text] [Related]
50. The prognostic value of CXCR4, MMP-2 and MMP-9 in tongue squamous carcinoma.
Ciucă FI; Mărăşescu PC; Matei M; Florescu AM; Mărgăritescu C; Demetrian AD; Drăgan I; Dumitrescu CI
Rom J Morphol Embryol; 2019; 60(1):59-68. PubMed ID: 31263828
[TBL] [Abstract][Full Text] [Related]
51. ERK phosphorylation functions in invadopodia formation in tongue cancer cells in a novel silicate fibre-based 3D cell culture system.
Noi M; Mukaisho KI; Yoshida S; Murakami S; Koshinuma S; Adachi T; Machida Y; Yamori M; Nakayama T; Yamamoto G; Sugihara H
Int J Oral Sci; 2018 Oct; 10(4):30. PubMed ID: 30344309
[TBL] [Abstract][Full Text] [Related]
52. Novel role for NFAT3 in ERK-mediated regulation of CXCR4.
Huang K; Kiefer C; Kamal A
PLoS One; 2014; 9(12):e115249. PubMed ID: 25514788
[TBL] [Abstract][Full Text] [Related]
53. A positive feedback loop of IL-17B-IL-17RB activates ERK/β-catenin to promote lung cancer metastasis.
Yang YF; Lee YC; Lo S; Chung YN; Hsieh YC; Chiu WC; Yuan SF
Cancer Lett; 2018 May; 422():44-55. PubMed ID: 29496538
[TBL] [Abstract][Full Text] [Related]
54. p75 neurotrophin receptor: A potential surface marker of tongue squamous cell carcinoma stem cells.
Tong D; Sun J; Huang P; Li M; Zhang F
Mol Med Rep; 2017 May; 15(5):2521-2529. PubMed ID: 28447720
[TBL] [Abstract][Full Text] [Related]
55. Gemfibrozil, a lipid-lowering drug, upregulates IL-1 receptor antagonist in mouse cortical neurons: implications for neuronal self-defense.
Corbett GT; Roy A; Pahan K
J Immunol; 2012 Jul; 189(2):1002-13. PubMed ID: 22706077
[TBL] [Abstract][Full Text] [Related]
56. IL-1β induces up-regulation of BIRC3, a gene involved in chemoresistance to doxorubicin in breast cancer cells.
Mendoza-Rodríguez M; Arévalo Romero H; Fuentes-Pananá EM; Ayala-Sumuano JT; Meza I
Cancer Lett; 2017 Apr; 390():39-44. PubMed ID: 28093282
[TBL] [Abstract][Full Text] [Related]
57. IL-1 Signaling in Tumor Microenvironment.
Zhang W; Borcherding N; Kolb R
Adv Exp Med Biol; 2020; 1240():1-23. PubMed ID: 32060884
[TBL] [Abstract][Full Text] [Related]
58. Interleukin-1 receptor antagonist inhibits matastatic potential by down-regulating CXCL12/CXCR4 signaling axis in colorectal cancer.
Ma J; Liang W; Qiang Y; Li L; Du J; Pan C; Chen B; Zhang C; Chen Y; Wang Q
Cell Commun Signal; 2021 Dec; 19(1):122. PubMed ID: 34930323
[TBL] [Abstract][Full Text] [Related]
59. Expression and function of interleukin-1β is required for hamster blastocyst hatching: Involvement of hatching-associated cathepsin proteases.
Pathak M; Vani V; Seshagiri PB
Mol Reprod Dev; 2021 Apr; 88(4):274-286. PubMed ID: 33719101
[TBL] [Abstract][Full Text] [Related]
60. IL-1β maintains the redox balance by regulating glutaredoxin 1 expression during oral carcinogenesis.
Chen X; Lv Q; Hong Y; Chen X; Cheng B; Wu T
J Oral Pathol Med; 2017 May; 46(5):332-339. PubMed ID: 27658048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
